Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Journal of Clinical Pharmacology
|
October 8, 2010
Clinical pharmacokinetics of tonapofylline: evaluation of dose proportionality, oral bioavailability, and gender and food effects in healthy human subjects
Zhaoyang Li, Christopher TenHoor, Thomas Marbury, et al.
Journal of Clinical Pharmacology
|
November 25, 2024
Sentinel Dosing-Time for a Risk-Based Approach?
Peter L Bonate, Mark Rogge, Jean-Michel Gries, et al.
Clinical Pharmacology and Therapeutics
|
April 24, 2003
Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis
Howard Lee, Hui C Kimko, Mark Rogge, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
August 7, 2002
Safety and systemic absorption of pulmonary delivered human IFN-beta1a in the nonhuman primate: comparison with subcutaneous dosing
Pauline L Martin, Sujata Vaidyanathan, Joan Lane, et al.
Clinical Pharmacology and Therapeutics
|
March 28, 2022
Asia-Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo
Karthik Venkatakrishnan, Neeraj Gupta, Patrick F Smith, et al.
Journal of Clinical Pharmacology
|
June 27, 2014
Pharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal function
Ping He, Doug Kerr, Thomas Marbury, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 17, 2024
Modeling serum M-protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasone
Yuki Otani, Yunqi Zhao, Guanyu Wang, et al.
Journal of Clinical Pharmacology
|
June 6, 2015
Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies
Lichuan Liu, Akintunde Bello, Mark J Dresser, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 1, 2026
Autosomal Dominant Tubulointerstitial Kidney Disease Clinical Trial Simulator: Case Reports of Model-Informed Drug Development
Shyam S Ramesh, Mark Rogge, Jongjin Kim, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 24, 2025
Quantifying clinical and genetic factors influencing rate and severity of autosomal dominant tubulointerstitial kidney disease progression
Shyam S Ramesh, Mark Rogge, Kendrah O Kidd, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Journal of Clinical Pharmacology
|
October 8, 2010
Clinical pharmacokinetics of tonapofylline: evaluation of dose proportionality, oral bioavailability, and gender and food effects in healthy human subjects
Zhaoyang Li, Christopher TenHoor, Thomas Marbury, et al.
Journal of Clinical Pharmacology
|
November 25, 2024
Sentinel Dosing-Time for a Risk-Based Approach?
Peter L Bonate, Mark Rogge, Jean-Michel Gries, et al.
Clinical Pharmacology and Therapeutics
|
April 24, 2003
Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis
Howard Lee, Hui C Kimko, Mark Rogge, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
August 7, 2002
Safety and systemic absorption of pulmonary delivered human IFN-beta1a in the nonhuman primate: comparison with subcutaneous dosing
Pauline L Martin, Sujata Vaidyanathan, Joan Lane, et al.
Clinical Pharmacology and Therapeutics
|
March 28, 2022
Asia-Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo
Karthik Venkatakrishnan, Neeraj Gupta, Patrick F Smith, et al.
Journal of Clinical Pharmacology
|
June 27, 2014
Pharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal function
Ping He, Doug Kerr, Thomas Marbury, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 17, 2024
Modeling serum M-protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasone
Yuki Otani, Yunqi Zhao, Guanyu Wang, et al.
Journal of Clinical Pharmacology
|
June 6, 2015
Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies
Lichuan Liu, Akintunde Bello, Mark J Dresser, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 1, 2026
Autosomal Dominant Tubulointerstitial Kidney Disease Clinical Trial Simulator: Case Reports of Model-Informed Drug Development
Shyam S Ramesh, Mark Rogge, Jongjin Kim, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 24, 2025
Quantifying clinical and genetic factors influencing rate and severity of autosomal dominant tubulointerstitial kidney disease progression
Shyam S Ramesh, Mark Rogge, Kendrah O Kidd, et al.
Page
of 3